J
Jonathan Feelemyer
Researcher at New York University
Publications - 75
Citations - 1327
Jonathan Feelemyer is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 17, co-authored 58 publications receiving 1008 citations. Previous affiliations of Jonathan Feelemyer include Icahn School of Medicine at Mount Sinai & Beth Israel Medical Center.
Papers
More filters
Journal ArticleDOI
Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review
Abu S. Abdul-Quader,Jonathan Feelemyer,Shilpa N. Modi,Ellen Stein,Alya Briceno,Salaam Semaan,Tara Horvath,Gail E Kennedy,Don C. Des Jarlais +8 more
TL;DR: The results support NSP as a structural-level intervention to reduce population-level infection and implementation of NSP for prevention and treatment of HIV and HCV infection.
Journal ArticleDOI
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas.
TL;DR: There was a significantly higher HIV prevalence among females compared to males who inject drugs in high seroprevalence settings, but the effect size is extremely modest.
Journal ArticleDOI
HIV Infection among Persons who inject Drugs: Ending Old Epidemics and Addressing New Outbreaks
TL;DR: Possible processes through which combined prevention programs may lead to ending HIV epidemics are examined, including in New York City, Vancouver and France, as well as in Scott County, Indiana, USA.
Journal ArticleDOI
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
TL;DR: WHOQOL-BREF and ASI domain scoring is a useful tool in measuring overall quality of life and levels of addiction among OST participants and should be further developed as integrated tools in the evaluation of participants in LMIC.
Journal ArticleDOI
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review
TL;DR: The data generally support the effectiveness of NSP in reducing HIV and HCV infection in low/middle-income and transitional-economy countries and if high coverage is achieved, NSP appear to be as effective in LMICs as in high-income countries.